Andreeff, Michael. (Eds.) () Targeted therapy of acute myeloid leukemia /MLA Citation
Andreeff, Michael,eds. Targeted Therapy Of Acute Myeloid Leukemia. : . Print.
These citations may not conform precisely to your selected citation style. Please use this display as a guideline and modify as needed.
Targeted therapy of acute myeloid leukemia /
Michael Andreeff, editor.
|Vernacular:||Introduction/Perspective -- Genetics and Classification of Acute Myeloid Leukemia -- Proteomics of AML to guide Selection of Therapy -- Roles of Apoptosis Regulating Bcl-2-Family Genes in AML -- Bcl-2 family: Translational aspects -- IAP Family and Proteins as Therapeutic Targets for Acute Myeloid Leukemia -- TP53 Mutations in Acute Myeloid Leukemia -- Targeting p53 Tumor Suppressor for AML Therapy -- AML-Selective Apoptosis Induction by rationally designed Death Ligand Fusion Protein -- PIM Kinases in AML -- Development of Midostaurin as a Tyrosine Kinase Inhabitor -- FLT3 in AML -- FLT3-ITD. Clinical (Sorafenib/AC220) -- Nucleophosmin (NPM1) -- Raf/MEK Pathway -- The Role of Translational Medicine in Optimization of Therapies targeting the RAS-MAP Kinase Pathway -- Clinical Use of Farnesyltransferase Inhititors -- The P13K-AKT-mTOR signaling Network in AML -- Targeting the P13 Kinase-mTOR Signaling Pathway in AML -- Aurora kinases -- The Clinical Development of Aurora Kinase Inhibitors in Acute Myeloid Leukemia -- AML-Deacetylases -- Methylation in AML-Clinical Applications -- Topic: RARa/RXR Part: Basic -- Arsenic Trioxide in Untreated APL -- Targeting PML-RARα with Retinoids -- NR4A Orphan Receptors as Drug Targets -- Antibody-based Therapeutics Targeting CD33, CD45, and CD66 -- New Heterogeneity of the Leukemic Stem Cells -- Targeting Leukemia Stem Cells -- Regulation of Hematopoiesis by CXCL12/CXCR4 Signaling -- CXC4/CXCL12 as a Therapeutic Target -- VLA-4: A Cell's Consequential Encounter -- VLA-4 Function and Prognosis in Acute Myeloid Leukemia -- VLA4 in Acute Lymphoblastic Leukemia -- The Leukemic Bone Marrow Microenvironment: Targeting Hypoxia with Hypoxia Activated Pro-Drugs -- Topic: miRs as Therapeutic Targets -- Clinical Implications of MicroRNAs in AML -- Inhibition of Glycolysis as a Therapeutic Strategy in Acute Myeloid Leukemias -- Molecular and Biochemical Basis for the Reprogramming of Intermediary Metabolism in Leukemia Cells -- NK Cell Immunotherapy for AML -- Allogeneic and Autologous T cell Strategies to Enhance Targeting of Acute Myeloid Leukemia -- Indications for Hematopoietic Transplantation for AML -- Mesenchymal Stem/Stromal Cell Targeted Therapies for Solid Tumors and Hematological Malignancies.
|Published:||New York : Springer, |
Current cancer research.
|Topics:||Acute myeloid leukemia - Treatment. | HEALTH & FITNESS - Diseases - General. | MEDICAL - Clinical Medicine. | MEDICAL - Diseases. | MEDICAL - Evidence-Based Medicine. | MEDICAL - Internal Medicine. | Leukemia, Myeloid. | Investigative Techniques | Drug Therapy. | Therapeutics. | Analytical, Diagnostic and Therapeutic Techniques and Equipment | Leukemia. | Neoplasms by Histologic Type | Disease. | Leukemia, Myeloid, Acute. | Molecular Targeted Therapy. | Methods. | Neoplasms. | Pharmacology. | Cellular biology (cytology) | Microbiology (non-medical) | Oncology.|
SpringerLink - Full text online (Opens in a new window)